Donidalorsen
ISIS 721744-CS8
Phase 3 small_molecule active
Quick answer
Donidalorsen for Hereditary Angioedema (HAE) is a Phase 3 program (small_molecule) at IONIS PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- IONIS PHARMACEUTICALS INC
- Indication
- Hereditary Angioedema (HAE)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active